Soc. Generale Call 850 Novo-Nordi.../ DE000SU9CV07 /
9/10/2024 1:02:37 PM | Chg.-0.130 | Bid1:42:22 PM | Ask1:42:22 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.500EUR | -4.94% | 2.510 Bid Size: 30,000 |
2.530 Ask Size: 30,000 |
- | 850.00 DKK | 6/19/2026 | Call |
Newsfile Corp
8/28
The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...
GlobeNewswire
8/28
Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire
8/28
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
GlobeNewswire
8/27
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Chil...
GlobeNewswire
8/26
Dewpoint Therapeutics Awarded Target ALS Grant for the Second Time for Development of c-mods for Amy...
GlobeNewswire
8/21
ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing
GlobeNewswire
8/14
19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...
GlobeNewswire
8/6
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Rea...
GlobeNewswire
8/1
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Dire...
GlobeNewswire
7/11
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansio...
GlobeNewswire
7/11
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pi...
GlobeNewswire
7/11
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pi...